Skip to main content
. 2025 Feb 7;9(7):1644–1657. doi: 10.1182/bloodadvances.2024015157

Table 3.

Toxicities for 16 patients treated with 19-28z CAR EBV-VSTs

Event (CTCAE grade) Overall cohort, n (%) Third-party donor cohort, n (%)
Number 16 12
CRS (grade 1) 1 (6) 1 (8)
Neurotoxicity 2 (13) 2 (13)
 Irritability (grade 2) 1 (6) 1 (8)
 Headache (grade 1) 1 (6) 1 (8)
Skin GVHD (grade 1) 1 (6) 1 (8)
Skin GVHD (grade 2) 1 (6) 1 (8)
Skin GVHD (grade 3) 1 (6)
Non-GVHD skin rash (grade 1) 2 (12)
Non-GVHD skin rash (grade 2) 2 (12) 2 (17)
Febrile neutropenia (grade 3) 1 (6)
Pneumonitis (grade 3) 1 (6) 1 (8)
Bone pain (grade 1) 1 (6) 1 (8)
Weight loss (grade 1) 1 (6) 1 (8)
Vomiting (grade 1) 1 (6) 1 (8)